Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02387203 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 19, 2024 (before its estimated December 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv8
  2. Primary completion date: Dec 2022 to Dec 2024v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Dec 2018 to Dec 2022 Primary endpoints: 3 to 1 · Trial status: Recruiting to Active, Not Recruiting · Completion date: Dec 2021 to Dec 2024 · 3 morev5 Show 6 more changesShow less
    • Primary endpoints: 3 to 1
    • Trial status: Recruiting to Active, Not Recruiting
    • Completion date: Dec 2021 to Dec 2024
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Eligibility criteria expanded, about 4 words

    See this version in full on ClinicalTrials.gov ↗

  5. Primary completion date: Dec 2016 to Dec 2018v4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Eligibility criteria expanded, about 1 wordv2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine the impact of antibiotic therapy on the disease progression and overall survival of patients with Pseudomyxoma Peritonei (PMP).
Trial Details
NCT Number NCT02387203
Lead Sponsor Mercy Medical Center
Conditions Pseudomyxoma Peritonei, Appendiceal Neoplasms
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov